Loading
BioArctic AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest was filed 04 Jun 2025.
BioArctic AB: what insiders have been doing
This page follows insider dealings at BioArctic AB as filed with Finansinspektionen, a company from the Health Care sector based in Stockholm Municipality, Sweden. The group dates from 2003. The last twelve months, up to 18 October 2026, brought 3 filings signed by 3 insiders.
All open-market trades in the period are sales: 3 sales worth €9.9M, by 3 insiders, with no purchase on record. Lars Lannfelt filed the largest sale, €4.9M, on 19 December 2025, which represents 0.19% of the company's market value.
Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. The regulation allows three business days to notify a trade (MAR article 19). Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Across the 890 companies tracked on its exchange, the median is 7 filings; at 3 filings, this issuer sits below that mark. Since 2025, the database holds 5 purchases and 5 sales by insiders of the company.
In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Key facts
Headquarters: Stockholm Municipality, Sweden · Founded: 2003
Source: Wikidata (CC0).
Insider Decl.
10
Thresholds
n/a
Buy Volume
€85,955
5 ops. · all time
Sell Volume
€10M
5 ops. · all time
Who traded when
BuySaleAnna-Kaija Grönblad2 sales
Oskar Bosson2 buys
Anders Martin-Löf1 buy
Anna-Lena Engvall1 buy
Biljana Rizoska1 sale
Lars Lannfelt1 sale
+2 other insiders
Since the insiders bought
- +53.1%Entry SEK 201.20 · Close at T+365 SEK 308.00
- +91.2%Entry SEK 168.10 · Close at T+365 SEK 321.40
- +91.2%Entry SEK 168.10 · Close at T+365 SEK 321.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate BioArctic AB Buy (bullish), based on 4 analysts. Average price target: SEK 316.75.
Fundamental score
Ranked 4,554 of 24,148 companies
67.5
score / 100
Value47
Quality88
FCF yld5.0%
Earn yld3.6%
EV/EBITDA22.4x
ROE10%
Gross mgn97%
Net mgn51%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 319.60
Analyst consensus
4 analystsBuy
SEK 280.00Target SEK 316.75(-1%)SEK 363.00
Income statement
RevenueSEK 2B
Gross profitSEK 1.9B97% margin
EBITDASEK 1.3B64% margin
Net incomeSEK 1B18.6% margin
Valuation
PER (trailing)134.9x
PER (forward)42.2x
P/Book12.9x
Beta-0.68
Balance sheet & cash
Market capSEK 28.4B
Total debtSEK 44.1M
Free Cash FlowSEK 1.4B
Debt / Equity2%
Profitability & ownership
ROE10.3%
ROA12.9%
% insiders42.7%
% institutions34.4%
Last declaration on 19 December 2025
Declarations10 total
173,750 shares@ SEK 310.000.19% mcap100.0% of flowAktieISIN SE0010323311FI:A003U935-1
173,750 shares@ SEK 310.000.19% mcap100.0% of flowAktieISIN SE0010323311FI:A003U936-1
500 shares@ SEK 316.400.0006% mcap5.1% of flowAktieISIN SE0010323311FI:A003U619-1
3,000 shares@ SEK 301.86860.0032% mcap100.0% of flowAktieISIN SE0010323311FI:A003R872-2
10,000 shares@ SEK 301.86860.011% mcap94.9% of flowAktieISIN SE0010323311FI:A003R873-2
1,750 shares@ SEK 194.100.0012% mcap91.4% of flowAktieISIN SE0010323311FI:A003P335-1
Canonical exit: 1 Sept 2025 (T+90)
2,422 shares@ SEK 163.200.0014% mcap100.0% of flowAktieISIN SE0010323311FI:A003N415-2
Canonical exit: 15 Jul 2025 (T+90)
198 shares@ SEK 163.200.0001% mcap8.6% of flowAktieISIN SE0010323311FI:A003N413-1
Canonical exit: 15 Jul 2025 (T+90)
500 shares@ SEK 164.700.0003% mcap100.0% of flowAktieISIN SE0010323311FI:A003N411-1
Canonical exit: 15 Jul 2025 (T+90)
448 shares@ SEK 222.400.0004% mcap100.0% of flowAktieISIN SE0010323311FI:A003M358-1
Canonical exit: 8 Jun 2025 (T+90)
10 of 10 declarations
About BioArctic AB
BioArctic AB is a Swedish biopharmaceutical company focused on developing treatments for neurodegenerative diseases. It is listed on the Stockholm Stock Exchange under the symbol XSTO.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
